why not losing weight on semaglutide am i any Why Am I Not Losing Weight on Semaglutide? Explained Why Am I Not Losing
Description
Exenatide formulations show variable nausea rates: the twice-daily immediate-release preparation (Byetta) tends to produce higher rates of nausea (approximately 3050%), whilst the once-weekly extended-release formulation (Bydureon) demonstrates improved tolerability with nausea rates of approximately 1424%, according to their respective SmPCs

PubMed Objective: Although the pathogenesis of non-alcoholic fatty liver disease (NAFLD) has been extensively studied, the role of its underlying pathogenesis remains unclear, and there is currently no approved therapeutic strategy for NAFLD
That distinction matters for clinicians designing care plans and for patients navigating an insurance landscape that still treats obesity and diabetes very differently

The brief administration timeusually 3-5 secondsfurther limits pain exposure during the injection itself
